Literature DB >> 31077902

Immediate Development of Dural Arteriovenous Fistula After Middle Meningeal Artery Embolization: First Angiographic Demonstration.

Lorenzo Piergallini1, Cyril Dargazanli2, Imad Derraz2, Vincent Costalat2.   

Abstract

BACKGROUND: Cerebral dural arteriovenous fistulas (DAVFs) are vascular lesions consisting of a pathologic high-flow connection between dural arteries and veins or dural sinuses. Small DAVFs shunts have been demonstrated to exist physiologically, but as their estimated diameter is around 8-12 μm, they are not visible even on high-quality angiography studies. CASE DESCRIPTION: We report 2 cases of immediate development of a DAVF after embolization with microparticles of the middle meningeal artery for treatment of chronic subdural hematoma.
CONCLUSIONS: This report represents the first description of sudden development of a DAVF after endovascular embolization of an intracranial artery and may shed light on the pathophysiology and development of DAVFs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dural arteriovenous fistula; Embolization; Endovascular therapy; Pathogenesis; Pathophysiology

Mesh:

Substances:

Year:  2019        PMID: 31077902     DOI: 10.1016/j.wneu.2019.04.246

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Intra-operative emergence of occult dural arteriovenous fistula after middle meningeal artery embolization for chronic subdural hematoma: Case report and literature review.

Authors:  Armin Tavakkoli; Julio D Montejo; Daniel R Calnan; Timothy C Ryken; Clifford J Eskey
Journal:  Radiol Case Rep       Date:  2022-03-03

Review 2.  Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives.

Authors:  Andrea Di Cristofori; Paolo Remida; Mirko Patassini; Lorenzo Piergallini; Raffaella Buonanno; Raffaele Bruno; Giorgio Carrabba; Giacomo Pavesi; Corrado Iaccarino; Carlo Giorgio Giussani
Journal:  Surg Neurol Int       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.